at-home-testing
(5)
Sheena Menezes
Sheena Menezes is the co-founder and CEO of Simple HealthKit, a Milpitas, California digital health company delivering accurate, affordable at-home diagnostics, treatment, and follow-up care. A biochemist with a PhD from UC Santa Barbara, where she discovered a novel tRNA methylase, she built her career in in-vitro diagnostics before founding Simple HealthKit to close socioeconomic gaps in healthcare access. Born and raised in Kuwait with Indian-Portuguese roots, she has been recognized by Fierce Healthcare as one of its Most Influential Minority Executives in Healthcare and named to Inc.'s 2025 Female Founders 500.
David Stein
David Stein is the co-founder and CEO of Ash (formerly Ash Wellness), a New York-based B2B platform that lets healthcare organizations run their own at-home testing programs. He launched the company out of Cornell Tech's MBA program in 2019 after a frustrating personal experience getting sexual health testing, first building a direct-to-consumer brand for the LGBTQ+ community and then pivoting to white-label infrastructure for providers and payers during COVID-19. Today Ash handles kit design, a CLIA/CAP-certified lab network, logistics, and patient-facing software across all 50 states, and has shipped more than a million test kits.
Ron Zohar
Ron Zohar is a co-founder and executive at Healthy.io, the Tel Aviv digital-health company that turns a smartphone camera into a clinical-grade medical device. He leads product and technology work behind Healthy.io's at-home urinalysis and wound-imaging platforms. A former Israeli Air Force officer with degrees in physics and philosophy from Tel Aviv University, he previously ran mobile product at Fiverr and co-founded Groovideo before helping build one of Israel's most-funded digital-health startups.
Luca Springer
Luca Springer is the co-founder and CEO of Numen (formerly Cleancard), a San Francisco synthetic-biology company building rapid at-home diagnostic tests that read biomarkers from a urine sample in about 30 minutes. A 2016 German Rhodes Scholar who once planned a career in European politics, he traded the policy track for the lab bench, pairing degrees in computer science and global governance from Oxford with a dual BA from Columbia and Sciences Po. He started the company in 2021 with fellow Rhodes Scholar Thomas Carroll, went through Y Combinator's Summer 2023 batch, and has raised roughly $5.1M to make lab-grade screening as simple as a pregnancy test.
Kara Egan
Kara Egan is the co-founder and CEO of Teal Health, the San Francisco-based company behind the Teal Wand - the first and only FDA-authorized at-home self-collection device for cervical cancer screening in the United States. A Stanford engineer-turned-Wharton MBA, Kara spent years as a venture capital investor at Emergence Capital and .406 Ventures before betting on a product she believed could remake an 80-year-old medical process. Backed by $23M from investors including Emerson Collective, Serena Ventures, and Forerunner, Teal Health has rapidly expanded nationwide with a device that studies show is just as accurate as in-clinic screening and preferred by 94% of women who tried it.